| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.044 | 0.9 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |